- Home
- PDS vs AQST Comparison
PDS vs AQST Comparison
Compare PDS & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PDS | AQST |
|---|---|---|
| Founded | 1951 | 2004 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 918.1M | 809.3M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | PDS | AQST |
|---|---|---|
| Price | $68.38 | $5.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $98.00 | $10.00 |
| AVG Volume (30 Days) | 76.5K | ★ 2.4M |
| Earning Date | 10-22-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.98 | N/A |
| Revenue | ★ $1,316,232,437.00 | $43,397,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.89 | $52.69 |
| P/E Ratio | $23.04 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $36.20 | $2.12 |
| 52 Week High | $71.77 | $7.55 |
Technical Indicators
Market Signals| Indicator | PDS | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 67.77 | 46.15 |
| Support Level | $56.10 | $5.99 |
| Resistance Level | $71.77 | $6.44 |
| Average True Range (ATR) | 2.29 | 0.33 |
| MACD | 0.49 | 0.00 |
| Stochastic Oscillator | 77.87 | 20.40 |
Price Performance
Historical ComparisonAbout PDS Precision Drilling Corporation
Precision Drilling Corp is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.